Cancer Cell International

Article	Citations
Identification and validation of ARF6 for a potential prognostic biomarker of acute myeloid leukemia	307
A multi-analyte liquid biopsy approach for nonseminomatous testicular germ cell tumors: combining cfDNA and N-glycan analysis in blood and seminal plasma	266
Mortalin promotes the evolution of androgen-independent prostate cancer through Wnt/β-catenin signaling pathway	240
Human amniotic epithelial cells exert anti-cancer effects through secretion of immunomodulatory small extracellular vesicles (sEV)	189
Syntaxin6 contributes to hepatocellular carcinoma tumorigenesis via enhancing STAT3 phosphorylation	146
PMA exerts anti-leukemia effect in Ph+ ALL through activating PKC δ and its down-stream molecules	139
Evaluation of functional magnetic resonance APT and DKI imaging for breast cancer	134
Revealing a novel Decorin-expressing tumor stromal subset in hepatocellular carcinoma via integrative analysis single-cell RNA sequencing	125
Unraveling the role of the solute carrier family in hepatocellular carcinoma: mechanisms and therapeutic prospects	115
Exploring the role of the disulfidptosis-related gene SLC7A11 in adrenocortical carcinoma: implications for prognosis, immune infiltration, and therapeutic strategies	108
Platinum-based drugs induce phenotypic alterations in nucleoli and Cajal bodies in prostate cancer cells	103
The addition of arginine deiminase potentiates Mithramycin A-induced cell death in patient-derived glioblastoma cells via ATF4 and cytochrome C	101
Deciphering 17-β-hydroxysteroid dehydrogenase 4: from molecular insights to cancer therapeutics	97
ASPM promotes the progression of esophageal squamous cell carcinoma by upregulating the expression of HMMR	92
Deciphering the prognostic features of bladder cancer through gemcitabine resistance and immune-related gene analysis and identifying potential small molecular drug PIK-75	91
Curcumin attenuates smoking and drinking activated NF-κB/IL-6 inflammatory signaling axis in cervical cancer	91
Imaging the metabolic reprograming of fatty acid synthesis pathway enables new diagnostic and therapeutic opportunity for breast cancer	86
ITC-6102RO, a novel B7-H3 antibody-drug conjugate, exhibits potent therapeutic effects against B7-H3 expressing solid tumors	85
Transcription factor MYB regulates glycolysis to promote the transfer and malignant progression of gastric cancer through the SSBP2/ISL1 axis	84
Anterior gradient 2 induces resistance to sorafenib via endoplasmic reticulum stress regulation in hepatocellular carcinoma	84
Retraction Note: Silencing of TRIM11 suppresses the tumorigenicity of chordoma cells through improving the activity of PHLPP1/AKT	84
MicroRNAome profiling of breast cancer unveils hsa-miR-5683 as a tumor suppressor microRNA predicting favorable clinical outcome	83
Potential role of P4HB in the tumor microenvironment and its clinical prognostic value: a comprehensive pan-cancer analysis and experimental validation with a focus on KIRC	82
Amino acid-based risk stratification model improves prognostic precision in diffuse large B-cell lymphoma	78
Venetoclax synergizes with Wnt/β-catenin inhibitor C-82 in acute myeloid leukemia by increasing the degradation of Mcl-1 protein	76

Targeting the CCL5/CCR5-PI3K-AKT axis suppresses hepatic stellate cell-induced breast cancer metastasis	72
CDK4 inhibition by luteolin enhances lenvatinib sensitivity in HCC via Wnt/β-catenin modulation	71
Low NDFIP1-driven metabolic alterations in CD8 + T cells: implications for immune evasion and therapy resistance in HNSC	71
Assessment of the anticancer and antimetastatic effects of monocarbonyl analogs of curcumin, C66 and B2BrBC, in breast cancer cells	69
Shared molecular mechanisms of common differentially expressed genes (C-DEGs) linking gallbladder stones to carcinogenesis: integrated bioinformatics and experimental validation	69
Iron metabolism: backfire of cancer cell stemness and therapeutic modalities	69
Smad2/3/4 complex could undergo liquid liquid phase separation and induce apoptosis through TAT in hepatocellular carcinoma	66
HOTAIR in cancer: diagnostic, prognostic, and therapeutic perspectives	62
SULF1 regulates malignant progression of colorectal cancer by modulating ARSH via FAK/PI3K/AKT/mTOR signaling	61
TAGLN: a stiffness-driven prognostic biomarker for metastatic colorectal cancer	61
SETDB1 promotes gastric cancer progression via UPR and mTOR pathway	61
Melanoma biology and treatment: a review of novel regulated cell death-based approaches	61
Molecular mechanisms of microRNA-216a during tumor progression	58
Disclosing a metabolic signature of cisplatin resistance in MDA-MB-231 triple-negative breast cancer cells by NMR metabolomics	58
Cuproptosis: a promising new target for breast cancer therapy	58
Muscone abrogates breast cancer progression through tumor angiogenic suppression via VEGF/PI3K/Akt/MAPK signaling pathways	57
OTUD3 inhibits breast cancer cell metastasis by regulating TGF-β pathway through deubiquitinating SMAD7	57
Metformin regulates the proliferation and motility of melanoma cells by modulating the LINC00094/miR-1270 axis	57
New models for MPNST: establishment and comprehensive characterization of two tumor cell lines	57
SLC25A17 inhibits autophagy to promote triple-negative breast cancer tumorigenesis by ROS-mediated JAK2/STAT3 signaling pathway	56
Spatial metabolomics on liver cirrhosis to hepatocellular carcinoma progression	55
Alantolactone enhances the sensitivity of melanoma to MAPK pathway inhibitors by targeting inhibition of STAT3 activation and down-regulating stem cell markers	54
TERT upstream promoter methylation regulates TERT expression and acts as a therapeutic target in TERT promoter mutation-negative thyroid cancer	53
Construction of a CCL20-centered circadian-signature based prognostic model in cervical cancer	53
Integrating bioinformatics and experimental validation to unveil disulfidptosis-related lncRNAs as prognostic biomarker and therapeutic target in hepatocellular carcinoma	53
Molecular and phenotypic characterization of 5-FU resistant colorectal cancer cells: toward enrichment of cancer stem cells	52
A multi-omics prognostic model integrating disulfidptosis-related molecular features in colorectal cancer	52
miR-196a-5p promotes the proliferation, migration, and invasion of esophageal squamous cell carcinoma by targeting LIFR	50
Etiology of polyploid giant cancer cells: a new frontier in cancer biology	50
Hepatocellular carcinoma drug resistance models	49
Microglia-mediated drug substance transfer promotes chemoresistance in brain tumors: insights from an in vitro co-culture model using GCV/Tk prodrug system	48
[email protected] nanoparticle for regulates the expression of GSDMB and targeted therapy of tumor	48
USP24 promotes hepatocellular carcinoma progression by deubiquitinating and stabilizing YAP1	48
Comprehensive analysis of ESCRT transcriptome-associated signatures and identification of the regulatory role of LMO7-AS1 in osteosarcoma	47
Development of a G2/M checkpoint subtype classifier for guiding precision therapy in liver hepatocellular carcinoma patients	47
Development and validation of a risk prediction model for overall survival in patients with nasopharyngeal carcinoma: a prospective cohort study in China	47
Anoikis-related signature predicts prognosis and characterizes immune landscape of ovarian cancer	46
Deapioplatycodin D inhibits glioblastoma cell proliferation by inducing BNIP3L-mediated incomplete mitophagy	46
A novel autoantibody signatures for enhanced clinical diagnosis of pancreatic ductal adenocarcinoma	46
Research on EBV-miR-BART17-5p targeted Inhibition of ARID1A expression to regulate nasopharyngeal carcinoma dedifferentiation	45
Spatial transcriptomics and single-cell analyses reveal the role of the cisplatin-resistant gene panel in NSCLC progression and the tumor microenvironment, identifying LOXL2 as a potential therapeutic	44
Identification of CD4_Naive cells related gene FMO4 as a positive regulator of the poor prognosis of septic CRC patients	43
Correction: Targeting WEE1 kinase as a p53-independent therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemia	43
Pomegranate juice and punicalagin-mediated chemoprevention of hepatocellular carcinogenesis via regulating miR-21 and NF-κB-p65 in a rat model	43
TSTA3 overexpression promotes malignant characteristics in LUSC by regulating LAMP2-mediated autophagy and tumor microenvironment	43
Divergent effects of topical deferoxamine treatment on skin and cancer cells uncovers its potential as a safe radioprotective agent in oncological applications	43
Interplay between lncRNA RP11-367G18.1 variant 2 and YY1 plays a vital role in hypoxia-mediated gene expression and tumorigenesis	43
Retraction Note: circRNA hsa_circRNA_0000069 promotes the proliferation, migration and invasion of cervical cancer through miR-873-5p/TUSC3 axis	42
STING pathway contributes to the prognosis of hepatocellular carcinoma and identification of prognostic gene signatures correlated to tumor microenvironment	42
Celastrol induces apoptosis of myelodysplastic syndrome cells through a ROS-dependent pro-apoptotic endoplasmic-reticulum stress pathway	41

Identifying disulfidptosis subtypes in hepatocellular carcinoma through machine learning and preliminary exploration of its connection with immunotherapy	40
DNA damage response signature-based prognostic genes for intrahepatic cholangiocarcinoma: a combined analysis of machine learning and biological experiments	40
Spatial and single-cell analyses uncover links between ALKBH1 and tumor-associated macrophages in gastric cancer	40
Hsa-miR-423-5p selectively loaded in hypoxic exosomes reduces the sensitivity of normoxic hepatocellular carcinoma to sorafenib via autophagy	40
Prediction of hepatocellular carcinoma prognosis and immunotherapeutic effects based on tryptophan metabolism-related genes	39
Inhibition of autophagy induced by tetrandrine promotes the accumulation of reactive oxygen species and sensitizes efficacy of tetrandrine in pancreatic cancer	39
The circRNA hsa-circ-0013561 regulates head and neck squamous cell carcinoma development via the miR-7-5p/PDK3 axis	38
Combining Mendelian randomization and multiomics data to determine the causal relationship between systemic inflammation and head and neck squamous cell carcinoma	38
LncRNA PGM5-AS1 inhibits non-small cell lung cancer progression by targeting miRNA-423-5p/SLIT2 axis	37
Development and validation of sensitive BCR::ABL1 fusion gene quantitation using next-generation sequencing	37
Nuclear-activating miRNAs: unveiling the intricacies of subcellular miRNA function and regulation in cancer and immunity disease	37
The role of platelets in tumor immune evasion and metastasis: mechanisms and therapeutic implications	36
Prolactin receptor signaling induces acquisition of chemoresistance and reduces clonogenicity in acute myeloid leukemia	36
ZNF655 promotes tumor growth and chemoresistance by targeting MAFF-CCND1 axis in ovarian cancer	36
C6orf15 promotes liver metastasis via WNT/β-catenin signalling in colorectal cancer	35
Multiomic traits reveal that critical irinotecan-related core regulator FSTL3 promotes CRC progression and affects ferroptosis	35
The function and mechanism of PSMD14 in promoting progression and resistance to anlotinib in osteosarcoma	35
Machine learning-based prognostic model of lactylation-related genes for predicting prognosis and immune infiltration in patients with lung adenocarcinoma	35
CAR-T cell combination therapy: the next revolution in cancer treatment	35
Co-delivery of camptothecin and SH3RF3-AS1 SiRNA for glioma synergistic therapy	35
The role of LncRNAs in tumor immunotherapy	34
CTCF-activated FUCA1 functions as a tumor suppressor by promoting autophagy flux and serum α-L-fucosidase serves as a potential biomarker for prognosis in ccRCC	34
High anti-tumor activity of a novel alpha-fetoprotein-maytansinoid conjugate targeting alpha-fetoprotein receptors in colorectal cancer xenograft model	34
Characterization of Circ_0048766: an oncogenic circular rna promoting triple-negative breast cancer progression via the miR-329-3p/CXCR4 axis and regulated by METTL3	34
An integrative framework combining Mendelian randomization, single-cell profiling, and experimental validation identifies FTMT as a mitochondrial–immune regulator in non-small cell lung cancer	34
Predicting survival of persons with newly-diagnosed multiple myeloma	34
Establishment of disulfidptosis-related LncRNA signature as biomarkers in colon adenocarcinoma	34
SLC9A9 links tumor immune infiltration to therapeutic response in colorectal cancer with emphasis on mismatch repair proficient subtype	33
Exploring the oncogenic mechanism of plasmacytoma variant translocation 1 (PVT1) gene in solid cancers; emphasis on microRNA regulation pathways	33
Construction of anti-tumor immune gene signature for HNSCC and identification of 4'-Hydroxywogonin as a potential immunotherapy combination drug	33
Personalized chemotherapy guided by drug sensitivity of circulating tumor cells improves outcomes in advanced biliary tract cancer	33
Molecular analysis of androgen receptor splice variant AR-V3 reveals eminent ambiguity regarding activity and clinical utility	32
Broussoflavonol B induces S-phase arrest and apoptosis in pancreatic cancer cells by modulating the cell cycle checkpoint through inhibition of the AURKA/PLK1 pathway	32
Circular RNA circPTPRF promotes the progression of GBM via sponging miR-1208 to up-regulate YY1	32
Evaluation of plasma cell sorting methods in multiple myeloma patients: flow cytometry versus magnetic beads	32
Adipocytes promote metastasis of breast cancer by attenuating the FOXO1 effects and regulating copper homeostasis	32
Complicated role of ALKBH5 in gastrointestinal cancer: an updated review	31
The upregulation of VGF enhances the progression of oral squamous carcinoma	31
Dysregulation of ferroptosis-related genes and the ACSL4-mediated ferroptosis-PD-L1 axis in prostate cancer pathogenesis	31
Whole exome sequencing identifies novel variants of PIK3CA and validation of hotspot mutation by droplet digital PCR in breast cancer among Indian population	31
Clinical application of cytokine-induced killer cells in cancer immunotherapy	31
Retraction Note: LncRNA HAND2-AS1 exerts anti-oncogenic effects on bladder cancer via restoration of RARB as a sponge of microRNA-146	31
Retraction Note: MicroRNA-93-5p promotes epithelial-mesenchymal transition in gastric cancer by repressing tumor suppressor AHNAK expression	31
Role of HOXA9 in solid tumors: mechanistic insights and therapeutic potential	31
Niosome-loaded silibinin and methotrexate for synergistic breast cancer combination chemotherapy: in silico and in vitro study	31
Integrated bioinformatics analysis of SEMA3C in tongue squamous cell carcinoma using machine-learning strategies	30
Migration and invasion of cancer stem cells are prevented by low-intensity pulsed ultrasound therapy	30
Machine learning for postoperative complication prediction and early recurrence risk assessment across cancer types: a systematic review and meta-analysis	30
Specificity protein 1 initiates epithelial-mesenchymal transition of circulating tumor cells to inhibit metastasis in prostate cancer	30
Characterization of pyruvate metabolism and citric acid cycle patterns predicts response to immunotherapeutic and ferroptosis in gastric cancer	30
Luteolin: a flavonoid with a multifaceted anticancer potential	29
Enhancing therapeutic efficacy in luminal androgen receptor triple-negative breast cancer: exploring chidamide and enzalutamide as a promising combination strategy	29
PPP2R1B abolishes colorectal cancer liver metastasis and sensitizes Oxaliplatin by inhibiting MAPK/ERK signaling pathway	29
Ferroptosis: insight into the treatment of hepatocellular carcinoma	29
Diverse activity of miR-150 in Tumor development: shedding light on the potential mechanisms	29
Molecular mechanisms involved in the anticancer activities of probiotics and postbiotics	29
Disulfidptosis in pediatric AML: a multi-omics approach to risk stratification and potential therapeutic strategy	28
The impact of gut bacteria producing long chain homologs of vitamin K2 on colorectal carcinogenesis	28
Involvement of abnormal dystroglycan expression and matriglycan levels in cancer pathogenesis	28
Role of the long non-coding RNAs in regulation of Gemcitabine response in tumor cells	28
E3 ubiquitin ligase HECW2: a promising target for tumour therapy	27
DUSP5 regulated by YTHDF1-mediated m6A modification promotes epithelial-mesenchymal transition and EGFR-TKI resistance via the TGF-β/Smad signaling pathway in lung adenocarcinoma	27
PIBF1 (p.R405Q) germline variant identified in cancer susceptibility family impairs protein stability and function	27
Interaction of AURKA with TRIM28 revives dormant LSCC cells via Akt signaling pathway to promote LSCC metastasis	27
Targeting WEE1 kinase as a p53-independent therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemia	27
Combinatorial phenethyl isothiocyanate and withaferin A targets multiple epigenetics pathways to inhibit MCF-7 and MDA-MB-231 human breast cancer cells	26
The emerging role of TROP2 as a diagnostic and prognostic biomarker in bladder tumor	26
Retraction Note: Knockdown of circRNA_0007534 suppresses the tumorigenesis of cervical cancer via miR-206/GREM1 axis	26
Identification and validation of a prognostic model based on three TLS-Related genes in oral squamous cell carcinoma	26
Correction: TEAD4 overexpression promotes epithelial-mesenchymal transition and associates with aggressiveness and adverse prognosis in head neck squamous cell carcinoma	26
Marine natural product Methyl mycophenolate inhibits gastric cancer growth through regulating p53 and the downstream pathways	26
miR-484 sensitizes in IDH-wild and IDH-mutant glioblastoma cells to temozolomide by inhibiting oncogenic FOXM1 signaling	26
circ_0061265 competitively binds to microRNA-885-3p to promote the development of gastric cancer by upregulating AURKA expression	26
Helicobacter pylori promotes gastric cancer progression via UPP1-mediated uridine bypass of glycolysis	26
Retraction Note: Berberine reduces temozolomide resistance by inducing autophagy via the ERK1/2 signaling pathway in glioblastoma	26
Real world analysis of the efficacy and safety of eribulin compared to utidelone in combination with capecitabine for the treatment of metastatic breast cancer	26
Mechanism study of oleanolic acid derivative, K73-03, inducing cell apoptosis in hepatocellular carcinoma	26
ARF6 promotes hepatocellular carcinoma proliferation through activating STAT3 signaling	25
Does rAj-Tspin, a novel peptide from A. japonicus, exert antihepatocellular carcinoma effects via the ITGB1/ZYX/FAK/AKT signaling pathway?	25
Biosensing chips for cancer diagnosis and treatment: a new wave towards clinical innovation	25

High LGALS3 expression induced by HCP5/hsa-miR-27b-3p correlates with poor prognosis and tumor immune infiltration in hepatocellular carcinoma	25
Distinct molecular pathways leading to dosage-dependent temozolomide resistance in GBM stem cells	25
From bioinformatics to bedside: PPBP drives glioblastoma progression under hypoxia via CXCR2/PI3K/Akt signaling and is targetable by Oenothein B	25
RGS20 promotes non-small cell lung carcinoma proliferation via autophagy activation and inhibition of the PKA-Hippo signaling pathway	25
Molecular mechanisms of inhibitor of growth (ING) family members in health and malignancy	25
Novel insights into the interaction between IGF2BPs and ncRNAs in cancers	25
The anti-tumor effects of AZD4547 on ovarian cancer cells: differential responses based on c-Met and FGF19/FGFR4 expression	24
Identification of fatty acids synthesis and metabolism-related gene signature and prediction of prognostic model in hepatocellular carcinoma	24
Salivary genetic biomarkers of lung cancer: a systematic review and meta-analysis of the diagnostic accuracy	24
Comprehensive analysis, diagnosis, prognosis, and cordycepin (CD) regulations for GSDME expressions in pan-cancers	24
Exosomal biomarkers and immune checkpoint inhibitors: advancements and future prospects	24
STAT3-mediated upregulation of LINC00520 contributed to temozolomide chemoresistance in glioblastoma by interacting with RNA-binding protein LIN28B	24
The expression of pro-prion, a transmembrane isoform of the prion protein, leads to the constitutive activation of the canonical Wnt/β-catenin pathway to sustain the stem-like phenotype of human gliob	24
TGFBI deficiency facilitates tumor associated macrophages M2 polarization and angiogenesis to promote pancreatic neuroendocrine neoplasms progression	24
Exosomal circPOLK promotes metastasis of NSCLC cells via regulating mir-1204/SOX8 axis	24
NSC777201 exhibits anticancer activity against colorectal cancer cells by inducing multiple types of cell death	24
Targeting the USP7-CDK1 axis suppresses estrogen receptor-positive breast cancer progression	24
Association of whole grain food consumption with lung cancer risk: a prospective cohort study	24
A comprehensive review about the utilization of immune checkpoint inhibitors and combination therapy in hepatocellular carcinoma: an updated review	23
Single-cell RNA sequencing in cancer research: discovering novel biomarkers and therapeutic targets for immune checkpoint blockade	23
Cannabidiol in pancreatic ductal adenocarcinoma: preclinical evidence, molecular mechanisms, and translational challenges	23
Oncogenic LINC00698 suppresses apoptosis of melanoma stem cells to promote tumorigenesis via LINC00698-miR-3132-TCF7/hnRNPM axis	23
Paris saponin VII suppresses osteosarcoma progression by targeting VEGFR2 and PD-L1 to enhance anti-angiogenic and immunotherapeutic efficacy	23
Exploring the effects of tinzaparin and cisplatin on lung cancer cells in vitro	23
LncRNA SNHG1: role in tumorigenesis of multiple human cancers	23
Transcriptomic landscape of TIMP3 oncosuppressor activity in thyroid carcinoma	23
Insights into the E2F target genes in breast cancer: associations of pathway genes with prognosis and immune cell filtration based on in silico and ex vivo analyses	23
8-Chloro-adenosine inhibits breast cancer progression by inducing ferroptosis via the ADAR1/miR-101-3p/SLC7A11 axis	23
A review on the role of mir-16-5p in the carcinogenesis	23
Domperidone inhibits cell proliferation via targeting MEK and CDK4 in esophageal squamous cell carcinoma	23
Retraction Note: Lnc-LRRTM4 promotes proliferation, metastasis and EMT of colorectal cancer through activating LRRTM4 transcription	23
Single-cell sequencing in bladder cancer: new insights from tumor cell diversity to individualized treatment strategies	22
Senescence-related circRNA circHIF-1α is associated with pancreatic cancer progression	22
Statins enhances antitumor effect of oxaliplatin in KRAS-mutated colorectal cancer cells and inhibits oxaliplatin-induced neuropathy	22
LTCONS_00014107-miR-29b-2-3p-GPR37 axis promotes heat stimulation induced esophageal carcinogenesis	22
Targeting cuproptosis for treatment and prognostic assessment in endometrial cancer	22
Novel a new prognostic model of thyroid carcinoma based on macrophage and cuproptosis-related lncRNA	22
LIS1 mediated Schwann cell reprogramming enhances perineural invasion by activating the serine/NMDAR/AKT signaling pathway in head and neck squamous carcinoma	22
Analysis of genetic biomarkers, polymorphisms in ADME-related genes and their impact on pharmacotherapy for prostate cancer	22
Environmental interpretation of the impact of vehicle emissions on prostate cancer progression	22
Exploring the role of pyroptosis in shaping the tumor microenvironment of colorectal cancer by bulk and single-cell RNA sequencing	22
Unraveling the oncogenic and immunomodulatory roles of GINS1: a systematic pan-cancer study	22
Impact of β3-adrenergic receptor agonist on tumor progression and metastasis in renal cell carcinoma models	22
An innovative model based on N7-methylguanosine-related lncRNAs for forecasting prognosis and tumor immune landscape in bladder cancer	21
Correction to: SIRT6/HIF-1α axis promotes papillary thyroid cancer progression by inducing epithelial–mesenchymal transition	21
Prognostic evaluation and experimental validation of cuproptosis-related hub genes identified through weighted gene co-expression network analysis in uveal melanoma	21
Mithramycin targets head and neck cancer stem cells by inhibiting Sp1 and UFMylation	21
Very long-chain fatty acids accumulate in breast cancer tissue and serum	21
A review of exercise-induced epigenetic modifications in prostate tissue: implications for gene expression and tumor progression in prostate cancer	21
A serum panel of three microRNAs may serve as possible biomarkers for kidney renal clear cell carcinoma	21
Identification and validation of a ferroptosis-related gene to predict survival outcomes and the immune microenvironment in lung adenocarcinoma	21
Methylome profiling reveals context-dependent chemo-resistance mechanisms and enhances risk stratification in AML	21
Biological roles of SLC16A1-AS1 lncRNA and its clinical impacts in tumors	21
MiR-155 deficiency and hypoxia results in metabolism switch in the leukemic B-cells	21
The role of m6A modification in non-small cell lung cancer: functional insights and impact on therapy resistance	21
Tumour cells can escape antiproliferative pressure by interferon-β through immunoediting of interferon receptor expression	21
Invasiveness-related microRNA expression in glioma: associations with clinical outcomes, tumor burden, and health-related quality of life	21
UCHL3: a crucial deubiquitinase in DNA damage repair and tumor progression	21
Role of m6A RNA methylation regulators in pancreatic cancer: interactions and potential implications	21
Targeting oral tumor microenvironment for effective therapy	20
Circulating IFNγ-associated protein signatures predict response to neoadjuvant immunotherapy in patients with stage III melanoma	20
Methylomics and cancer: the current state of methylation profiling and marker development for clinical care	20
Disruption of DMD gene leads to altered calcium homeostasis and metabolic shift impacting gastric Cancer cell proliferation and migration	20
Sensitization of hepatocellular carcinoma cells to HDACi is regulated through hsa-miR-342-5p/CFL1	20
LncRNA SPINT1-AS1 enhances the Warburg effect and promotes the progression of osteosarcoma via the miR-135b-5p/PGAM1 axis	20
Integrating multi-omics data revealing LIMK1 as a metastatic biomarker in LUAD patients with brain metastasis	20
Unveiling the oncogenic role of SLC25A13: a multi-omics pan-cancer analysis reveals its impact on glioma progression	20
Flavonoids target different molecules of autophagic and metastatic pathways in cancer cells	20
ALDH18A1 regulates glutamine metabolism and tumor microenvironment in the attenuation of clear cell renal cell carcinoma	20
MDM2: current research status and prospects of tumor treatment	20
Green-synthesized MnFe₂O₄/GO nanocomposites: structural characterization, cytotoxicity, and potential for targeted cervical cancer therapy	20
PTX3 facilitates tumor cell migration and invasion through the miR-1255b-2-3p/CYP2J2 axis in oral squamous cell carcinoma	20
Efficacy of MAGE-A4 long peptide as a universal immunoprevention cancer vaccine	20
Are chemical compounds in medical mushrooms potent against colorectal cancer carcinogenesis and antimicrobial growth?	20
Development and validation of a disulfidptosis and disulfide metabolism-related risk index for predicting prognosis in lung adenocarcinoma	20
Evaluation of X-ray and carbon-ion beam irradiation with chemotherapy for the treatment of cervical adenocarcinoma cells in 2D and 3D cultures	20
NUDT1 drives osteosarcoma progression and serves as a robust predictor of clinical outcomes	20
Advancing the therapeutic effectiveness of paclitaxel in chronic lymphocytic leukemia through the simultaneous inhibition of NOTCH1 and SF3B1	20
ADAM8 is expressed widely in breast cancer and predicts poor outcome in hormone receptor positive, HER-2 negative patients	20
Prognostic significance of Lymphocyte-activation gene 3 (LAG3) in patients with solid tumors: a systematic review, meta-analysis and pan-cancer analysis	20
MSI2 regulates NLK-mediated EMT and PI3K/AKT/mTOR pathway to promote pancreatic cancer progression	20
Targeted suppression of DNA polymerase θ enhances calcium flux and triggers intrinsic apoptosis in gastric cancer	19
Recent advances on high-efficiency of microRNAs in different types of lung cancer: a comprehensive review	19
Correction: TRPM2: a pivotal player in tumor progression and a promising therapeutic target	19
Correction: Current view of liver cancer cell-of-origin and proposed mechanisms precluding its proper determination	19
Transforming bone cancer treatment: a comprehensive review of green-synthesized metal nanoparticles	19
Single cell sequencing deciphering the heterogeneous landscape of blastic plasmacytoid dendritic cell neoplasm with novel MYB-ZFAT fusion gene	19
Establishment and characterization of a new intrahepatic cholangiocarcinoma cell line derived from a Chinese patient	19
CCDC25 suppresses clear cell renal cell carcinoma progression by LATS1/YAP-mediated regulation of the hippo pathway	19
Correction: The various role of microRNAs in breast cancer angiogenesis, with a special focus on novel miRNA-based delivery strategies	19
Machine learning-based prognostic model and single-cell transcriptomic integration for identifying brain metastasis-associated malignant subpopulations and potential therapeutic targets in lung adenoc	19
Gastric cancer cell-originated small extracellular vesicle induces metabolic reprogramming of BM-MSCs through ERK-PPARγ-CPT1A signaling to potentiate lymphatic metastasis	19
ncRNAs-mediated overexpression of STIL predict unfavorable prognosis and correlated with the efficacy of immunotherapy of hepatocellular carcinoma	19
Construction and validation of acetylation-related gene signatures for immune landscape analysis and prognostication risk prediction in luminal breast cancer	19
Expression of HECTD2 predicts peritoneal metastasis of gastric cancer and reconstructs immune microenvironment	19